Cargando…

Protective effects and mechanisms of psoralidin against adriamycin-induced cardiotoxicity

INTRODUCTION: Adriamycin (ADR) is an efficient and common broad-spectrum anticancer drug. However, the cumulative and dose-dependent toxicity induced by ADR severely limits its application in the clinic. Previous studies found that psoralidin (PSO) exhibits remarkable therapeutic effects against mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Zhenxing, Chen, Ying, Wang, Zheng, Wu, Xue, Deng, Chao, Wang, Changyu, Yang, Wenwen, Tian, Ye, Zhang, Shaofei, Lu, Chenxi, Yang, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481943/ https://www.ncbi.nlm.nih.gov/pubmed/36100330 http://dx.doi.org/10.1016/j.jare.2021.12.007

Ejemplares similares

Protective effect of melatonin against Adriamycin-induced cardiotoxicity
por: ZHANG, YAN, et al.
Publicado: (2013)

Protection of zero-valent iron nanoparticles against sepsis and septic heart failure
por: Wang, Daquan, et al.
Publicado: (2022)

Adriamycin cardiotoxicity monitoring by radionuclide scan.
por: Robinson, B. A., et al.
Publicado: (1983)

Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin
por: Zhu, Hong, et al.
Publicado: (2014)

Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.
por: Klugmann, F. B., et al.
Publicado: (1986)

Activation of NR1H3 attenuates the severity of septic myocardial injury by inhibiting NLRP3 inflammasome
por: Deng, Chao, et al.
Publicado: (2023)

A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity
por: Xiao, Mengjie, et al.
Publicado: (2021)

Pharmacological Activities of Psoralidin: A Comprehensive Review of the Molecular Mechanisms of Action
por: Sharifi-Rad, Javad, et al.
Publicado: (2020)

Protection against acute adriamycin-induced cardiotoxicity by garlic: Role of endogenous antioxidants and inhibition of TNF-α expression
por: Mukherjee, Sumanta, et al.
Publicado: (2003)

Psoralidin induces autophagy through ROS generation which inhibits the proliferation of human lung cancer A549 cells
por: Hao, Wenhui, et al.
Publicado: (2014)

Kudzu Celery Decoction Exerts Protection against Sepsis-Induced Myocardial Injury
por: Zhao, Lin, et al.
Publicado: (2022)

Potential Protective Effect of Achillea fragrantissima against Adriamycin-Induced Cardiotoxicity in Rats via an Antioxidant and Anti-Inflammatory Pathway
por: Hijazi, Maha A., et al.
Publicado: (2019)

Cytoprotective and antioxidant effects of aged garlic extract against adriamycin-induced cardiotoxicity in adult male rats
por: Nasr, Ashraf Youssef, et al.
Publicado: (2020)

The Coumarin Psoralidin Enhances Anticancer Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
por: Bronikowska, Joanna, et al.
Publicado: (2012)

Protection of melatonin treatment and combination with traditional antibiotics against septic myocardial injury
por: Di, Wencheng, et al.
Publicado: (2023)

Oral Delivery of Psoralidin by Mucoadhesive Surface-Modified Bilosomes Showed Boosted Apoptotic and Necrotic Effects against Breast and Lung Cancer Cells
por: Youness, Rana Ahmed, et al.
Publicado: (2023)

Cardioprotective Mechanism and Active Compounds of Folium Ginkgo on Adriamycin-Induced Cardiotoxicity: A Network Pharmacology Study
por: Sun, Xue, et al.
Publicado: (2022)

Psoralidin prevents caffeine-induced damage and abnormal differentiation of bone marrow mesenchymal stem cells via the classical estrogen receptor pathway
por: Hua, Rong, et al.
Publicado: (2021)

Effect of Adriamycin on DNA, RNA and Protein Biosyntheses in Mouse Tissues, in Connection with Its Cardiotoxicity
por: Sazuka, Yasuyuki, et al.
Publicado: (1989)

Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin
por: Wang, Yingying, et al.
Publicado: (2020)

The RNA binding protein hnRNPK protects against adriamycin-induced podocyte injury
por: Zhao, Shili, et al.
Publicado: (2021)

Glibenclamide exacerbates adriamycin-induced cardiotoxicity by activating oxidative stress-induced endoplasmic reticulum stress in rats
por: Liu, Meng-Lin, et al.
Publicado: (2018)

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
por: Cheah, Irwin K., et al.
Publicado: (2023)

Phoenix dactylifera Protects against Doxorubicin-Induced Cardiotoxicity and Nephrotoxicity
por: Wang, Yuewen, et al.
Publicado: (2019)

Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity via Maintaining Mitochondrial Homeostasis
por: Li, Lin, et al.
Publicado: (2020)

Shengmai injection combined with conventional therapy in treating Adriamycin-related cardiotoxicity: A protocol for systematic review and meta-analysis of randomized controlled trials
por: Liu, Lanchun, et al.
Publicado: (2020)

Neuroprotective Effects of Omentin-1 Against Cerebral Hypoxia/Reoxygenation Injury via Activating GAS6/Axl Signaling Pathway in Neuroblastoma Cells
por: Niu, Xiaochen, et al.
Publicado: (2022)

Psoralidin inhibits osteosarcoma growth and metastasis by downregulating ITGB1 expression via the FAK and PI3K/Akt signaling pathways
por: Cheng, Shengwen, et al.
Publicado: (2023)

Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway
por: Li, Ling-Li, et al.
Publicado: (2020)

Protective Mechanism of Hydrogen Sulfide against Chemotherapy-Induced Cardiotoxicity
por: Du, Shuxu, et al.
Publicado: (2018)

Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro
por: Sun, Jing, et al.
Publicado: (2013)

Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study
por: QuanJun, Yang, et al.
Publicado: (2017)

Sugemule-3 Protects against Isoprenaline-induced Cardiotoxicity In vitro
por: Wang, Yu, et al.
Publicado: (2017)

In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity
por: Chen, Chih-Tai, et al.
Publicado: (2015)

Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells
por: Pereira-Oliveira, Maria, et al.
Publicado: (2019)

In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity
por: Zhou, Peng, et al.
Publicado: (2022)

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
por: Hole, Lisa Drange, et al.
Publicado: (2014)

Protective effect of silymarin against chemical-induced cardiotoxicity
por: Razavi, Bibi Marjan, et al.
Publicado: (2016)

Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity
por: Ulusan, Sebahat, et al.
Publicado: (2023)

Honokiol protects against doxorubicin cardiotoxicity via improving mitochondrial function in mouse hearts
por: Huang, Lizhen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7bqdmfr9hvfegm70nh7grhbknl